{"id":125356,"date":"2021-07-23T12:22:59","date_gmt":"2021-07-23T19:22:59","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2021\/07\/dr-spring-behrouz-phd-mitophagy-cns-disorders-and-aging-ceo-vincere-bio-neuroinitiative"},"modified":"2021-07-23T12:22:59","modified_gmt":"2021-07-23T19:22:59","slug":"dr-spring-behrouz-phd-mitophagy-cns-disorders-and-aging-ceo-vincere-bio-neuroinitiative","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2021\/07\/dr-spring-behrouz-phd-mitophagy-cns-disorders-and-aging-ceo-vincere-bio-neuroinitiative","title":{"rendered":"Dr Spring Behrouz, PhD \u2014 Mitophagy, CNS Disorders, And Aging \u2014 CEO, Vincere Bio \/ NeuroInitiative"},"content":{"rendered":"<p><\/p>\n<p><iframe style=\"display: block; margin: 0 auto; width: 100%; aspect-ratio: 4\/3; object-fit: contain;\" src=\"https:\/\/www.youtube.com\/embed\/_fBqPEWz8os?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; encrypted-media; gyroscope;\n   picture-in-picture\" allowfullscreen><\/iframe><\/p>\n<p>Mitochondrial Quality Control (Mitophagy), CNS Disorders, and Aging \u2014 Dr. Spring Behrouz, Ph.D., CEO, Vincere Biosciences Inc. \/ CEO, Neuroinitiative LLC.<\/p>\n<hr>\n<p>Dr. Bahareh (Spring) Behrouz, PhD, is the CEO of Vincere Biosciences Inc (<a href=\"https:\/\/vincerebio.com\/),\">https:\/\/vincerebio.com\/),<\/a> a biotech company focused on developing novel, small molecule therapeutics targeting mitochondrial pathways and the improvement of mitochondrial quality.<\/p>\n<p>Dr. Behrouz is also the CEO of NeuroInitiative, LLC (<a href=\"https:\/\/www.neuroinitiative.com\/),\">https:\/\/www.neuroinitiative.com\/),<\/a> a computational biology company she co-founded in 2014, which develops simulations of disease using their patented software platform. A core focus of her research at NeuroInitiative is on the elucidation of complex, converging pathways that contribute to the pathogenesis of Parkinson\u2019s disease (PD), a neuro-degenerative brain disorder which dramatically effects movement, which nearly one million people in the U.S. are living with, and 10 million patients worldwide.<\/p>\n<p>Dr. Behrouz received her graduate training at Michigan State University in the laboratory of Dr. John Goudreau and studied differential susceptibility of dopaminergic neuron sub-types in models of PD. She completed her post-doctoral training in the laboratory of Dr. Matthew Farrer at the Mayo Clinic in Jacksonville, where she primarily focused on in-vivo and primary culture models of LRRK2-mediated pathogenesis and was part of the team that discovered a new pathogenic mutation in VPS35.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Mitochondrial Quality Control (Mitophagy), CNS Disorders, and Aging \u2014 Dr. Spring Behrouz, Ph.D., CEO, Vincere Biosciences Inc. \/ CEO, Neuroinitiative LLC. Dr. Bahareh (Spring) Behrouz, PhD, is the CEO of Vincere Biosciences Inc (https:\/\/vincerebio.com\/), a biotech company focused on developing novel, small molecule therapeutics targeting mitochondrial pathways and the improvement of mitochondrial quality. Dr. Behrouz [\u2026]<\/p>\n","protected":false},"author":400,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,1523,269,47],"tags":[],"class_list":["post-125356","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-computing","category-life-extension","category-neuroscience"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/125356","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/400"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=125356"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/125356\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=125356"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=125356"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=125356"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}